about
Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegenerationDysregulated axonal RNA translation in amyotrophic lateral sclerosisNovel molecular biomarkers at the blood-brain barrier in ALSA Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During DiseaseRiluzole increases the amount of latent HSF1 for an amplified heat shock response and cytoprotectionGDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.Modelling amyotrophic lateral sclerosis: progress and possibilitiesDisrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection.D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosisPhysical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence.Persistent inward currents in spinal motoneurons: important for normal function but potentially harmful after spinal cord injury and in amyotrophic lateral sclerosis.Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1.Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model.Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS.Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies.State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.Inducing Chronic Excitotoxicity in the Mouse Spinal Cord to Investigate Lower Motor Neuron Degeneration.Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects.Survey of ALS-associated factors potentially promoting Ca2+ overload of motor neurons.Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS.State of the art and the dark side of amyotrophic lateral sclerosis.Emerging drugs for amyotrophic lateral sclerosis.Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.Axonal degeneration as a therapeutic target in the CNS.Understanding ALS: new therapeutic approaches.A review of experimental research on herbal compounds in amyotrophic lateral sclerosis.Astrocytic vesicle mobility in health and disease.Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis.The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzoleDownregulation of the potassium chloride cotransporter KCC2 in vulnerable motoneurons in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis.Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons.Cumulative effect of 5 daily sessions of θ burst stimulation on corticospinal excitability in amyotrophic lateral sclerosis.Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model.Antagonistic molecular interactions of photosynthetic pigments with molecular disease targets: a new approach to treat AD and ALS.Neurobrucellosis presenting as clinically definite amyotrophic lateral sclerosis.
P2860
Q24613053-C98FEFA3-5D9D-47D6-9B11-8E964E0537F4Q26753110-6E27CE17-F373-42D9-BA41-333D08303737Q27004431-0F6887D7-AC71-43AF-BBA5-8814B1FD1A90Q28079299-13BDE059-38B7-4FBA-8C78-0AADDE69455CQ28473241-15230471-A33F-4351-95EA-E498B38218B4Q33292690-519F3320-803F-4B0F-AF26-7F52ED5C7808Q33418312-B1A6CC35-080C-4069-A928-8CA19BF4B8ECQ33657315-3738B347-EA41-4D3F-AD34-9363538B0ABDQ33746289-D62B7925-2C4A-431F-8522-3AC6A4991BBEQ33789174-0507FA76-B0A4-4646-A990-74CF7A7D8548Q34006224-9C02A440-8E24-4247-972A-A5C277B87B57Q34016411-36E9EB7D-4B07-4D94-814B-0958D243CEC8Q34399203-B7D2F33E-F432-40FC-B15E-6AC83BB289F4Q34961354-244E5894-55AB-4A0B-AB60-ED3BA513EDD5Q35772761-D67E3EB7-D0F6-429E-8DDF-8A6D5E04E623Q35951394-4064E271-3434-4220-A2BD-E530F3904B3AQ36302933-20C08A81-CC4D-44C5-B144-CD46A4542BABQ36494315-467837BF-4AB9-49C5-A0FA-FC3C7C5509A9Q36637186-4DDA420F-94BB-449E-AB0A-C5145F1D4A2AQ36710448-9CDDC087-E5BD-46C9-BCFD-4C92B360DD79Q36961660-B1811BE6-51B2-410E-AD1E-060215AED813Q37538542-D60E549E-0933-4A42-B383-C6BF34F6C970Q37871837-6273F3A5-2E26-48DF-8A1F-FFF86FD45519Q37909351-C7BE552A-E397-4718-9991-524D81F31765Q37952528-0EC7890E-F5C3-46FB-9F90-8F2F51F692FAQ37990880-0D56874D-EF2C-4C91-8156-EB693C1A2B95Q38065343-C32CB51F-F66A-4D09-AA6F-0212AF717325Q38092021-F4B72FEE-D74A-4AD8-BF6D-743BF2C69038Q38109828-2A6B07ED-720B-4464-8746-87C108514855Q38741121-2DACF637-47EF-4E3E-9352-B51D2A1C592FQ39217922-BFACA8FA-3B4C-4703-9AE3-E934531E9476Q42395440-C957AB3C-E06A-44A2-B3E9-995E4215347BQ42908670-3E56242A-5FE5-43AD-922F-9F48DF3F0019Q43011186-E5D4CE65-B3CE-46B8-82BF-A692EA4499BDQ45148790-09E6CCF4-31C9-446A-ABC1-9258A6CC34AFQ45332429-7DC9C7B7-A016-47C3-8DA1-C179EF6156A6Q45881781-C77F7F97-5D53-42CF-951D-EAF76C35D7D3Q48139092-39012FA7-4593-4DC7-9DA3-E00F7971B0F8Q49342725-602DCFFE-7F37-4E0A-A796-7F1C7C8397AC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Excitotoxicity and amyotrophic lateral sclerosis.
@ast
Excitotoxicity and amyotrophic lateral sclerosis.
@en
type
label
Excitotoxicity and amyotrophic lateral sclerosis.
@ast
Excitotoxicity and amyotrophic lateral sclerosis.
@en
prefLabel
Excitotoxicity and amyotrophic lateral sclerosis.
@ast
Excitotoxicity and amyotrophic lateral sclerosis.
@en
P2093
P2860
P356
P1476
Excitotoxicity and amyotrophic lateral sclerosis
@en
P2093
Robberecht W
Van Damme P
P2860
P304
P356
10.1159/000089620
P577
2005-01-01T00:00:00Z